A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.
Suemori K, Saijo M, Yamanaka A, Himeji D, Kawamura M, Haku T, Hidaka M, Kamikokuryo C, Kakihana Y, Azuma T, Takenaka K, Takahashi T, Furumoto A, Ishimaru T, Ishida M, Kaneko M, Kadowaki N, Ikeda K, Sakabe S, Taniguchi T, Ohge H, Kurosu T, Yoshikawa T, Shimojima M, Yasukawa M.
Suemori K, et al. Among authors: taniguchi t.
PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009103. doi: 10.1371/journal.pntd.0009103. eCollection 2021 Feb.
PLoS Negl Trop Dis. 2021.
PMID: 33617533
Free PMC article.